Alnylam Pharmace. buy SpringheelJack
Start price
08.05.20
/
50%
€130.98
Target price
08.07.20
-
Performance (%)
7.97%
End price
08.07.20
€141.42
Summary
This prediction ended on 08.07.20 with a price of €141.42. With a performance of 7.97%, the BUY prediction by SpringheelJack for Alnylam Pharmace. closed with a slight gain. SpringheelJack has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -0.651% | -0.651% | 23.205% | 58.378% |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% | 53.313% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% | 93.480% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% | 52.317% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% | 66.737% |
Comments by SpringheelJack for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.